Impaired seroconversion after SARS-CoV-2 mRNA vaccines in patients with solid tumours receiving anticancer treatment - Amatu, Alessio; Pani, Arianna; Patelli, Giorgio; Gagliardi, Oscar M.; Loparco, Marina; Piscazzi, Daniele; Cassingena, Andrea; Tosi, Federica; Ghezzi, Silvia; Campisi, Daniela; Grifantini, Renata; Abrignani, Sergio; et al. (European journal of cancer (1990), 2022)
Keywords: 2019-nCoV Vaccine mRNA-1273 - administration & dosage; 2019-nCoV Vaccine mRNA-1273 - immunology; Adult; Aged; Antibodies; Antibodies, Viral - blood; Biomarkers - blood; BNT162 Vaccine - administration & dosage; BNT162 Vaccine - immunology; Cancer; Cancer therapies; Case-Control Studies; Chemotherapy; COVID-19; Drug dosages; Female; Health services; Humans; Immunization; Immunogenicity; Immunogenicity, Vaccine; Immunotherapy; Italy; Logit models; Male; Metastases; Middle Aged; mRNA; mRNA vaccines; Multivariate analysis; Neoplasms - immunology; Neoplasms - therapy; Original Research; Patients; Population; Population studies; Prospective Studies; Regression analysis; Risk Factors; Seroconversion; Severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; Solid tumors; Time Factors; Treatment Outcome; Tumors; Vaccination; Vaccine; Vaccine Efficacy; Vaccines; Viral diseases; Italy; COVID-19; Chemotherapy; Immunogenicity; Immunotherapy; Vaccine; Seroconversion; Cancer